Tink > Personally I think the stock is dramatically undervalued compared to its peers.
I don't know. Part of the valuation of a company is how many years it was loosing money. How many failures it accumulated. SGMO is a leader among it's pears,
simply by doing this much, much longer. Long before CRISPR was a word :-(
It seems we are at a cusp of a success or a disaster. If Hemo A does not deliver or other positive news does not surface, the stock will be severely punished. While the company may survive, those of us who are up to ears in SGMO may not..
I worry about loosing all my money, not about "CEO held accountable", whatever this means (getting a golden parachute, moving to another company and getting a bunch of new stock?)